BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 31261175)

  • 1. Cancer cell-derived tissue factor-positive extracellular vesicles: biomarkers of thrombosis and survival.
    Hisada Y; Mackman N
    Curr Opin Hematol; 2019 Sep; 26(5):349-356. PubMed ID: 31261175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tissue factor-positive extracellular vesicles and their association with thrombosis in different diseases.
    Hisada Y; Sachetto ATA; Mackman N
    Immunol Rev; 2022 Nov; 312(1):61-75. PubMed ID: 35708588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue Factor and Extracellular Vesicles: Activation of Coagulation and Impact on Survival in Cancer.
    Hisada Y; Mackman N
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast-cancer extracellular vesicles induce platelet activation and aggregation by tissue factor-independent and -dependent mechanisms.
    Gomes FG; Sandim V; Almeida VH; Rondon AMR; Succar BB; Hottz ED; Leal AC; Verçoza BRF; Rodrigues JCF; Bozza PT; Zingali RB; Monteiro RQ
    Thromb Res; 2017 Nov; 159():24-32. PubMed ID: 28950217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-level secretion of tissue factor-rich extracellular vesicles from ovarian cancer cells mediated by filamin-A and protease-activated receptors.
    Koizume S; Ito S; Yoshioka Y; Kanayama T; Nakamura Y; Yoshihara M; Yamada R; Ochiya T; Ruf W; Miyagi E; Hirahara F; Miyagi Y
    Thromb Haemost; 2016 Jan; 115(2):299-310. PubMed ID: 26446354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update from the laboratory: mechanistic studies of pathways of cancer-associated venous thrombosis using mouse models.
    Hisada Y; Mackman N
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):182-186. PubMed ID: 31808871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of tissue factor-positive extracellular vesicles by laser scanning confocal microscopy.
    Hisada Y; Auriemma AC; Alexander W; Ay C; Mackman N
    Thromb Res; 2017 Feb; 150():65-72. PubMed ID: 28043041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue factor expression, extracellular vesicles, and thrombosis after infection with the respiratory viruses influenza A virus and coronavirus.
    Mackman N; Grover SP; Antoniak S
    J Thromb Haemost; 2021 Nov; 19(11):2652-2658. PubMed ID: 34418279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Cell-Derived Extracellular Vesicles Are Associated with Coagulopathy Causing Ischemic Stroke via Tissue Factor-Independent Way: The OASIS-CANCER Study.
    Bang OY; Chung JW; Lee MJ; Kim SJ; Cho YH; Kim GM; Chung CS; Lee KH; Ahn MJ; Moon GJ
    PLoS One; 2016; 11(7):e0159170. PubMed ID: 27427978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PML-RARa modulates the vascular signature of extracellular vesicles released by acute promyelocytic leukemia cells.
    Fang Y; Garnier D; Lee TH; D'Asti E; Montermini L; Meehan B; Rak J
    Angiogenesis; 2016 Jan; 19(1):25-38. PubMed ID: 26374632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential biomarker profiles between unprovoked venous thromboembolism and cancer.
    Sánchez-López V; Gao L; Ferrer-Galván M; Arellano-Orden E; Elías-Hernández T; Jara-Palomares L; Asensio-Cruz MI; Castro-Pérez MJ; Rodríguez-Martorell FJ; Lobo-Beristain JL; Ballaz-Quincoces A; López-Campos JL; Vila-Liante V; Otero-Candelera R
    Ann Med; 2020 Sep; 52(6):310-320. PubMed ID: 32634035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Aspects of Extracellular Vesicles as Mediators of Cancer-Associated Thrombosis.
    Almeida VH; Rondon AMR; Gomes T; Monteiro RQ
    Cells; 2019 Jul; 8(7):. PubMed ID: 31337034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway.
    Lombardo G; Gili M; Grange C; Cavallari C; Dentelli P; Togliatto G; Taverna D; Camussi G; Brizzi MF
    Oncogene; 2018 Mar; 37(9):1175-1191. PubMed ID: 29238040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucin 1 and venous thrombosis in tumor-bearing mice and patients with cancer.
    Kawano T; Englisch C; Hisada Y; Paul D; Archibald S; Grover S; Pabinger I; Ay C; Mackman N
    Thromb Res; 2024 May; 237():23-30. PubMed ID: 38547690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size.
    Hisada Y; Ay C; Auriemma AC; Cooley BC; Mackman N
    J Thromb Haemost; 2017 Nov; 15(11):2208-2217. PubMed ID: 28834179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologically Active Tissue Factor-Bearing Larger Ectosome-Like Extracellular Vesicles in Malignant Effusions from Ovarian Cancer Patients: Correlation with Incidence of Thrombosis.
    Steidel C; Ender F; Rody A; von Bubnoff N; Gieseler F
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated blood plasma levels of tissue factor-bearing extracellular vesicles in patients with atrial fibrillation.
    Mørk M; Andreasen JJ; Rasmussen LH; Lip GYH; Pedersen S; Bæk R; Jørgensen MM; Kristensen SR
    Thromb Res; 2019 Jan; 173():141-150. PubMed ID: 30530119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicles as biomarkers and therapeutic targets for cancer.
    Urabe F; Kosaka N; Ito K; Kimura T; Egawa S; Ochiya T
    Am J Physiol Cell Physiol; 2020 Jan; 318(1):C29-C39. PubMed ID: 31693397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia.
    Gheldof D; Haguet H; Dogné JM; Bouvy C; Graux C; George F; Sonet A; Chatelain C; Chatelain B; Mullier F
    J Thromb Thrombolysis; 2017 Feb; 43(2):224-232. PubMed ID: 28074413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesicles.
    Tawil N; Bassawon R; Meehan B; Nehme A; Montermini L; Gayden T; De Jay N; Spinelli C; Chennakrishnaiah S; Choi D; Adnani L; Zeinieh M; Jabado N; Kleinman CL; Witcher M; Riazalhosseini Y; Key NS; Schiff D; Grover SP; Mackman N; Couturier CP; Petrecca K; Suvà ML; Patel A; Tirosh I; Najafabadi H; Rak J
    Blood Adv; 2021 Mar; 5(6):1682-1694. PubMed ID: 33720339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.